A combination product comprising melagatran and a factor viia inhibitor

Details for Australian Patent Application No. 2001264495 (hide)

Owner AstraZeneca AB

Inventors Mattsson, Christer; Bylund, Ruth

Agent Davies Collison Cave

Pub. Number AU-B-2001264495

PCT Pub. Number WO01/95932

Priority 0014134 10.06.00 GB

Filing date 6 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 5 January 2006

International Classifications

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

5 January 2006 Application Accepted

  Published as AU-B-2001264495

4 May 2006 Standard Patent Sealed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001264496-Propulsion system for a ship

2001264494-A combination product comprising melagatran and a factor xa inhibitor